According to the WHO, lower respiratory tract infections are one of the most prevalent causes of death in Africa. Estimates based on verbal autopsies are inaccurate compared with the gold standard for determining cause of death, the anatomical postmortem. Here, we review all respiratory postmortem data available from Africa and assess disease prevalence by HIV status in both adults and children.
INTRODUCTION
In Africa, according to the WHO, tuberculosis (TB) and other lower respiratory tract infections (LRTIs) are the most prevalent infectious causes of death, accounting for roughly 1.5 million deaths in 2008 [1] . This figure does not include 1.3 million deaths recorded as 'due to HIV/AIDS', where the specific cause of death is not reported [1] (Fig. 1) . Together, TB, LRTIs and HIV/AIDS are thought to be responsible for over half of all infectious disease deaths in Africa. Despite significant successes with the rollout of antiretroviral therapy (ART) across the continent over the past decade [2, 3] , there were still 1.2 million AIDS-related deaths across Africa in 2010 and infectious diseases of the lung were reported as one of the major causes [4] .
WHO cause-specific mortality estimates are based on data from national governments and international aid programmes [1] , but population-wide monitoring of the pathogen-specific cause of death in many African countries is limited. The data that are collected come from a range of sources, mainly from clinical records and verbal autopsy studies, which are inaccurate. The gold standard for determining cause of death is through anatomical postmortem examination, observing gross disease, and if facilities are available, histopathological and microbiological investigation [5] .
Postmortem studies give an indication of how accurate (or inaccurate) the premortem clinical diagnosis was, and the information obtained can have a significant impact on clinical management guidelines and local policy to improve clinical practice [5] . Postmortem studies are particularly useful for distinguishing between infections with similar clinical presentation and can identify other coinfections where multiple pathogens may have contributed to disease, or infectious comorbidity with AIDS-related malignancies and other noncommunicable diseases [6] . Conducting postmortem studies in some African cultural contexts is challenging [7, 8] , and so the number and heterogeneity of such studies is limited, making population-based estimates of cause-specific mortality difficult.
Here, we review the findings of all African published postmortem studies conducted to date. We present pooled data on the overall prevalence of different lung diseases, stratified by age and HIV status, and highlight levels of coinfection and correlation with clinical diagnosis.
SEARCH METHODOLOGY
The Pubmed database was searched using the term 'post mortem' OR 'Autopsy' AND 'Africa' AND 'HIV', which returned 148 articles. Twentyone original postmortem studies were identified, in which the results of either complete (trunk organs and brain) or partial postmortems (typically restricted to the chest cavity) are reported. Thirty-seven articles were verbal autopsy studies or reviews on verbal autopsy methodologies. Verbal autopsy studies were not the focus of this review as they cannot differentiate between the specific pathogens responsible for causing LRTIs, and so were excluded [9] . The remaining 90 articles were also excluded: one article did not delineate postmortem findings between adults and children, 64 did not report any cause-specific mortality data relating to HIV-associated lung disease in Africa, nine were reviews, eight articles presented case studies, seven contained duplicate data or substudies, which overlapped with the selected studies (typically such articles focussed on a
KEY POINTS
Pulmonary infections are the most common cause of death seen at autopsy in Africa.
Pulmonary and extrapulmonary TB are seen in up to 69% of HIV-associated adult deaths.
Coinfections with multiple pathogens were seen in up to 66% of HIV-associated childhood deaths.
Correlation between clinical-determined and postmortem-determined cause of death is low.
There is a great need for more investment into rapid and accurate diagnostics for respiratory tract infections, especially in HIV-infected children and adults. specific pathogen), and one article was in French (Fig. 2 ).
POSTMORTEM STUDY RECRUITMENT AND DESCRIPTIVES
This review presents the results of 21 studies, 12 in adults and nine in children. Table 1 summarizes the recruitment characteristics for both adult and childhood studies, and illustrates clearly the heterogeneous nature of the studies undertaken [10] [11] [12] [13] [14] 15 && , 16-20,21 & ,22-29] . All studies focused on inpatient deaths, but one included community mortalities brought in for forensic examination [13] . Four studies (all paediatric) selected patients specifically because they died with respiratory infections [6, 25, 26, 28] , or even more specifically, because they had a premortem diagnosis of TB [19] . Studies took place over a 20-year period, from 1992 to 2012, across 11 different African countries. Studies from West Africa included patients with HIV-2 as well as HIV-1 infection [10, 11, 20, 22] . Three South African studies were from mining communities where lung disease would be expected to be more prevalent [18,19,30 & ]. Paediatric studies tended to focus on young infants under 12 months of age.
All but four of the studies included in this review required relatives of the deceased to consent. Pooling the recruitment rates across those consenting studies for which the data are available suggests that in both adult and childhood studies, recruitment of HIV-associated deaths may be slightly easier than non-HIV associated deaths (Table 1) . AIDS patients and their families may have spent more time in the health system and might be more sensitized to the rationale of research studies. Only one of the four nonconsenting studies had a recruitment rate of 100%, highlighting that it is not only the requirement for consent that impairs postmortem study recruitment rates, but sufficient trained pathologists and support personnel, and morgue and laboratory facilities are also required to undertake a representative number of postmortems in the given time frame. Ten out of 12 adult and six out of nine childhood studies declare an open bias towards either HIV or respiratory infections, and so these studies present an excellent opportunity to review cause-specific mortality in HIV-associated respiratory deaths across Africa. ], the results of 1273 postmortem examinations are reported. The HIV status is presented for 99% (1260/1273) of cases, with the majority (80.3%, 1012/1260) being HIV-positive mortalities. All of the studies were undertaken at secondary or tertiary referral centres where up to 70% of patients admitted may be HIV positive, with 60-66% of mortalities being among HIV-infected patients [10, 31] . One study also included community deaths [10] . Reviewing the 12 studies, we extracted six key respiratory disease groups stated as either the primary or contributory cause of death: pulmonary TB, extrapulmonary or disseminated TB infection, bacterial pneumonia, Pneumocystis jirovecci pneumonia (PCP), human cytomegalovirus (HCMV) pneumonia and interstitial pneumonia. Pooling the data from all studies we assessed the prevalence of each disease group within the total number of autopsies undertaken, stratifying by HIV status. Among HIVinfected mortalities, pulmonary TB was the most prominent cause of death, with prevalence being 4.2-fold higher than among HIV-uninfected mortalities [35% (335/902) vs. 8.8% (20/226); P < 0.001]. Similarly, extrapulmonary or disseminated TB infections were 5.2-fold more prevalent in HIV-infected vs.
ADULT POSTMORTEM STUDY FINDINGS
HIV-uninfected mortalities [20.8% (188/902) vs. 4% (9/226); P < 0.001]. The prevalence of bacterial pneumonia did not differ by HIV status [27.7% (250/902) vs. 29.2% (66/226); P ¼ 0.656]. PCP and HCMV pneumonia were detected in 5.3 and 7.5% of HIV-infected patients only, and were not detected at all in HIVuninfected mortalities. Interstitial pneumonia was detected in 5% of cases or less, with no significant difference observed between HIV-infected and HIVuninfected mortalities (Fig. 3 ).
Pubmed search for ("post mortem" or "autopsy") and "Africa" and "HIV"* 148 articles (15 th Nov 2012)
Exclusions = 127
No cause specific mortality data from Africa n = 65 Verbal autopsy studies n = 37 Reviews n = 9 Case studies n = 8 21 post mortem studies *Keywords relating to respiratory disease were not included so as not to over-restrict the search 
CHILDHOOD POSTMORTEM STUDY FINDINGS
We extracted data from nine paediatric postmortem studies undertaken in Africa between 1996 and 2003 [6, [22] [23] [24] [25] [26] [27] [28] [29] . From a total of 832 postmortems, 72.7% (605/832) were in HIV-infected children. The most prevalent contributory cause of death identified in all childhood studies was bacterial pneumonia, with significantly higher prevalence in HIV-uninfected vs. HIV-infected children [56.4% (128/227) vs. 43 .5% (263/605), P < 0.001] (Fig. 4) extrapulmonary or disseminated TB were documented, and all of these were in HIV-infected children.
COINFECTION WITH MULTIPLE PATHOGENS
Two adult [17, 19] and four paediatric studies [6, 25, 27, 29] explicitly state the prevalence of cases with multiple pathogens, with coinfection rates between 34 and 47% in adult mortalities, and between 46 and 66% in children (data not shown).
CORRELATION WITH CLINICAL DIAGNOSIS
Of the 21 studies analysed in this review, just seven provide a comparison of clinical vs. pathological diagnoses. Raw data for TB were presented in five studies [16, [18] [19] [20] 32] . Pooling of the results from these studies, and combing both HIV-infected and uninfected cases, shows that clinical diagnosis for TB has an overall sensitivity of 67.3% [95% confidence interval (CI) 60.3-73.7] and a specificity of 89.1% (95% CI 85.1-92.1) ( Table 2 ).
DISCUSSION
Respiratory tract infections and HIV/AIDS are important causes of death in Africa. They are caused by an array of bacterial, mycobacterial, fungal and viral pathogens. As rapid, cheap and accurate diagnostic technologies are not widely available, many patients are treated empirically on the basis of clinical suspicion. Postmortem studies are the gold standard for determining both primary and secondary causes of death, and the results of such studies can be used to evaluate the accuracy of clinical diagnoses and to uncover missed causes of death and complex coinfections [5, 33] . Current opinion on postmortem data from respiratory mortalities in HIV/AIDS in Africa is based on the relatively small number of postmortem studies that have been conducted over the last two decades. The 21 postmortem studies presented in this review show pooled data for pulmonary TB, extrapulmonary or disseminated TB, bacterial pneumonia, PCP, HCMV pneumonia and interstitial pneumonia in adults and children, stratified by HIV status. For HIV-infected adults, TB (both pulmonary and extrapulmonary or disseminated infections) was the most common finding at postmortem, being detected in up to 69% of HIVassociated deaths [15 && ], with a three to four-fold increase in prevalence among HIV-infected vs. HIVuninfected cases. Although widespread roll-out of ART services across the continent over the past decade has resulted in overall decreases in all-cause mortality [34] , some centres have documented that the prevalence of TB as a primary cause of death is actually increasing, possibly due to a shift in focus from TB to ART services, and likely also due to population level demographic changes over time [30 & ]. In HIV-uninfected adults, we identified pneumonia as the most common finding at postmortem.
All but four of the reviewed postmortem studies required the consent of the deceased's relatives. Pooled recruitment rates across all studies, which provided the raw data, suggest that up to 20% of those families who are approached give consent, with rates being slightly higher for HIV-infected cases. Although some studies have documented reasons for refusal to take part in postmortem studies [7] , it is difficult to interpret this with respect to how the recruited postmortem study group may or may not be representative of the wider population. It is possible that deaths which were sudden and unexplained, or for which the relatives are not completely satisfied with the explanation given by the attending physician, might be more likely to be recruited. This might favour atypical clinical presentations, possibly caused by coinfection with multiple pathogens.
Some of the studies reviewed illustrate a high prevalence of coinfections with multiple pathogens in HIV/AIDS mortalities: 34-47% in adults [17, 19] , and 46-66% in children [6, 25, 27, 29] . These studies almost exclusively recruited cases from inpatient deaths, but it has been estimated that up to half of all AIDS patients die at home [16] . It is not known whether causes of death differ between hospitalized and community deaths. Home deaths might plausibly be more likely to be late-stage mortalities, with patients maybe previously admitted, going home for palliative care. Conversely, earlier mortalities, such as those linked with ART initiation, might be more likely to occur in hospitalized patients. The majority of adult studies and all childhood studies present data from postmortems undertaken prior to ART roll-out, and so just the most recent postmortem study reported cause-specific mortality results by ART treatment status: they found TB in 87% of early ART deaths, compared with 57% in pre-ART and 60% in late-stage deaths, respectively [15 && ]. From the nine childhood postmortem studies, bacterial pneumonia was the most prevalent cause of death, being significantly more prevalent in HIVuninfected than in HIV-infected children. This differential was compensated by a 10-fold higher prevalence of both PCP and HCMV pneumonia in HIV-infected children. We show here that both PCP and HCMV are important causes of mortality in HIV-infected children, particularly those younger than 1 year of age [6, 27] . PCP is now treated empirically with cotrimoxazole in all HIV-infected children, but for HCMV neither diagnostics nor treatment (intravenous ganciclovir) is generally available outside of certain referral centres in South Africa, where pilot data suggest that ganciclovir can dramatically reduce mortality in antibioticunresponsive HIV-associated severe pneumonia [35, 36] . Pulmonary TB was much less prevalent in children than in adults, but still accounted for roughly 10% of deaths, and was slightly more prevalent in HIV-uninfected children. Children typically contract pulmonary TB from an adult relative, and it was interesting to note that HIV-uninfected children were at a similar risk for TB infection as HIV-infected children. Maternal HIV status was not recorded and it is likely that a significant proportion of childhood TB deaths, certainly in young infants, were in children who were maternally exposed to HIV, which has been shown to be linked with increased morbidity and mortality [37] [38] [39] . Most of the childhood postmortems in which pulmonary TB was identified as a primary cause of death came from one study, which highlights a broader point that there have been too few studies performed to properly assess both historical trends and geographical variation in the mortality contribution of different infections across Africa. The most recent childhood postmortem study was from 2003, and there is an urgent need for recent cause of death data from both HIV-infected children on ART and maternally exposed children from across the continent.
Lay interpretation of publications, which present disparity between clinical and pathological diagnoses, may be politically sensitive, and expose hospital authorities to either justified or unjustified criticism. It is maybe for this reason that only five of the 21 postmortem studies reviewed present raw data on correlation with clinical diagnosis. We present the pooled performance of clinical diagnosis for TB compared with postmortem findings from these five studies [16, [18] [19] [20] 32] , demonstrating an overall sensitivity of just 67.3%. All five studies were undertaken relatively recently (four within the last 5 years) and at tertiary hospitals where laboratory results such as smear microscopy and mycobacterial culture would have been available and informed on clinical diagnosis premortem. In a recent record review study, TB was missed premortem in 23 of 44 (52%) cases, and wrongly attributed as the cause of death in 16% (18/110) of cases [40] . This occurred at a well-funded private hospital in South Africa, but most HIV-associated respiratory deaths in Africa occur at poorly resourced health centres where laboratory facilities are limited.
CONCLUSION
WHO estimates state that infectious diseases remain the primary cause of death in Africa, accounting for 65% of all deaths. Noncommunicable disease account for 28% of all deaths, and although the prevalence of diseases such as diabetes, cancer and stroke are rising [41] , infectious diseases, and in particular, respiratory infections, will likely remain a priority for the foreseeable future [42] . Much of the HIV respiratory mortality data reviewed here comes from postmortem examinations conducted on ART-naive mortalities. With the steady expansion of ART treatment services across Africa [43] , there is a great need for new postmortem data, ideally from large unified multisite studies with a simple methodology that is easily replicated [21 & ]. Due to the sensitive nature of postmortem studies, and cultural differences between heterogeneous African societies, new techniques such as fine-needle biopsy could be employed to make studies less traumatic and more culturally acceptable [33] . Current priorities include children and adults on ART [15 && ], HIVinfected and/or maternally exposed children, and maternal deaths which have been broadly neglected [14, 32, 44] . The high death rate in Africa due to LRTIs illustrates that there is an urgent need for new, rapid and accurate diagnostic tools for a range of respiratory pathogens, to help clinicians interpret complex and overlapping clinical symptoms, and to get more patients onto appropriate pathogen-targeted therapy.
